The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Early sirtuin 2 inhibition prevents age-related cognitive decline in a senescence-accelerated mouse model
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the one hand, aging correlates with heightened SIRT2 expression in the brain (Maxwell et al., 2011;Garg et al., 2017;Diaz-Perdigon et al., 2020;Li et al., 2023), suggesting the potential interest of its pharmacological inhibition as a therapeutic strategy for neurodegenerative diseases.”
From Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer’s disease (2025) · cites this paper as Diaz-Perdigon et al., 2020
In the citing paper
“SIRT2 has been identified as a key regulator of aging (Garmendia-Berges et al., 2023;Diaz-Perdigon et al., 2020)”
From Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer’s disease (2025) · cites this paper as Diaz-Perdigon et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., Yuan, H., Myers, S. J., & Dingledine, R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002451 · Cited by 3,568
Intervening in ageing to prevent the diseases of ageing
Partridge, L. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.08.003 · Cited by 69
Sun, C. Y., Qi, S. S., Zhou, P., Cui, H. R., Chen, S. X., Dai, K. Y., & Tang, M. L. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.02.002 · Cited by 44
Research works printed but not linked: 65
- Akbarian S, Beeri MS, Haroutunian V. Epigenetic determinants of healthy and diseased brain aging and cognition. JAMA Neurol 2013;70:711–8. · DOI
- Brunet A, Berger SL. Epigenetics of aging and aging-related disease. J Gerontol Ser A Biol Sci Med Sci 2014;69:S17–20. · DOI · Paper page
- Guzman-Martinez L, Maccioni RB, Farías GA, Fuentes P, Navarrete LP. Biomarkers for Alzheimer’s disease. Curr Alzheimer Res. 2019;16;518–28. · DOI · Paper page
- Gräff J, Tsai L-H. The potential of HDAC inhibitors as cognitive enhancers. Annu Rev Pharm Toxicol 2013;53:311–30. · DOI · Paper page
- Sharma M, Shetty MS, Arumugam TV, Sajikumar S. Histone deacetylase 3 inhibition re-establishes synaptic tagging and capture in aging through the activation of nuclear factor kappa B. Sci Rep 2015;5:16616.
- Mastroeni D, et al. Epigenetic mechanisms in Alzheimer’s disease. Neurobiol Aging 2011;32:1161–80. · DOI · Paper page
- Jayasena T, et al. Application of targeted mass spectrometry for the quantification of sirtuins in the central nervous system. Sci Rep 2016;6:35391. · DOI · Paper page
- Eskandarian HA, et al. A role for SIRT2-dependent histone H3K18 deacetylation in bacterial infection. Science 2013;341:1238858. · DOI · Paper page
- Suzuki K, Koike T. Mammalian Sir2-related protein (SIRT) 2–mediated modulation of resistance to axonal degeneration in slow Wallerian degeneration mice: a crucial role of tubulin deacetylation. Neuroscience 2007;147:599–612. · DOI
- Pfister JA, Ma C, Morrison BE, D’Mello SR. Opposing effects of sirtuins on neuronal survival: SIRT1-mediated neuroprotection is independent of its deacetylase activity. PLoS ONE 2008;3:e4090. · DOI · Paper page
- Maxwell MM, et al. The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS. Hum Mol Genet 2011;20:3986–96. · DOI · Paper page
- Anwar T, Khosla S, Ramakrishna G. Increased expression of SIRT2 is a novel marker of cellular senescence and is dependent on wild type p53 status. Cell Cycle 2016;15:1883–97. · DOI
- Outeiro TF, et al. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson’s disease. Science 2007;317:516–9. · DOI · Paper page
- Chopra V, et al. The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington’s disease mouse models. Cell Rep 2012;2:1492–7. · DOI · Paper page
- de Oliveira RM, et al. The mechanism of sirtuin 2–mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease. PLoS Biol 2017;15:e2000374. · DOI · Paper page
- Erburu M, et al. SIRT2 inhibition modulate glutamate and serotonin systems in the prefrontal cortex and induces antidepressant-like action. Neuropharmacology 2017;117:195–208. · DOI · Paper page
- Muñoz-Cobo I, Belloch FB, Díaz-Perdigón T, Puerta E, Tordera RM. SIRT2 inhibition reverses anhedonia in the VGLUT1+/- depression model. Behav Brain Res 2017;335:128–31. · DOI
- Polito L, et al. The SIRT2 polymorphism rs10410544 and risk of Alzheimer’s disease in two Caucasian case-control cohorts. Alzheimers Dement 2013;9:392–9. · DOI
- Wei W, et al. The SIRT2 polymorphism rs10410544 and risk of Alzheimer’s disease: a meta-analysis. Neuromolecular Med 2014;16:448–56. · DOI
- Cacabelos R, et al. Sirtuins in Alzheimer’s disease: SIRT2-related genophenotypes and implications for pharmacoepigenetics. Int J Mol Sci 2019;20:1249. · DOI
- Spires-Jones TL, et al. Inhibition of sirtuin 2 with sulfobenzoic acid derivative AK1 is non-toxic and potentially neuroprotective in a mouse model of frontotemporal dementia. Front Pharmacol 2012;3:42.
- Biella G, et al. Sirtuin 2 inhibition improves cognitive performance and acts on amyloid-β protein precursor processing in two Alzheimer’s disease mouse models. J Alzheimers Dis 2016;53:1193–207. · DOI · Paper page
- Silva DF, Esteves AR, Oliveira CR, Cardoso SM. Mitochondrial metabolism power SIRT2-dependent deficient traffic causing Alzheimer’s-disease related pathology. Mol Neurobiol 2017;54:4021–40. · DOI
- Esteves AR, et al. Acetylation as a major determinant to microtubule-dependent autophagy: relevance to Alzheimer’s and Parkinson disease pathology. Biochim Biophys Acta. 2018. https://doi.org/10.1016/j.bbadis.2018.11.014 . · DOI · Paper page
- Tomobe K, Nomura Y. Neurochemistry, neuropathology, and heredity in SAMP8: a mouse model of senescence. Neurochem Res 2009;34:660–9. · DOI
- Pallas M, et al. From aging to Alzheimer’s disease: unveiling "the switch" with the senescence-accelerated mouse model (SAMP8). J Alzheimers Dis 2008;15:615–24. · DOI · Paper page
- Griñán-Ferré C, et al. Understanding epigenetics in the neurodegeneration of Alzheimer’s disease: SAMP8 mouse model. J Alzheimers Dis 2018;62:943–63. · DOI
- Cosín-Tomás M, et al. Epigenetic alterations in hippocampus of SAMP8 senescent mice and modulation by voluntary physical exercise. Front Aging Neurosci 2014;6:51.
- Cosín-Tomás M, et al. Temporal integrative analysis of mRNA and microRNAs expression profiles and epigenetic alterations in female SAMP8, a model of age-related cognitive decline. Front Genet 2018;9:596. · DOI
- Griñan-Ferré C, et al. Environmental enrichment modified epigenetic mechanisms in SAMP8 mouse hippocampus by reducing oxidative stress and inflammaging and achieving neuroprotection. Front Aging Neurosci 2016;8:241. · DOI
- Griñan-Ferré C, et al. Environmental enrichment improves behavior, cognition, and brain functional markers in young senescence-accelerated prone mice (SAMP8). Mol Neurobiol 2016;53:2435–50. · DOI
- Suzuki T, et al. Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors. J Med Chem 2012;55:5760–73. · DOI
- Flood JF, Farr SA, Kaiser FE, Morley JE. Age-related impairment in learning but not memory in SAMP8 female mice. Pharm Biochem Behav 1995;50:661–4. · DOI
- Orejana L, Barros-Miñones L, Aguirre N, Puerta E. Implication of JNK pathway on tau pathology and cognitive decline in a senescence-accelerated mouse model. Exp Gerontol 2013;48:565–71. · DOI
- Orejana L, Barros-Miñones L, Jordán J, Puerta E, Aguirre N. Sildenafil ameliorates cognitive deficits and tau pathology in a senescence-accelerated mouse model. Neurobiol Aging 2012;33:625.e11–20. · DOI
- Orejana L, et al. Sildenafil decreases BACE1 and cathepsin B levels and reduces APP amyloidogenic processing in the SAMP8 mouse. J Gerontol Ser A Biol Sci Med Sci 2015;70:675–85. · DOI
- García-Osta A, Cuadrado-Tejedor M. Advanced assay monitoring APP-carboxyl-terminal fragments as markers of APP processing in Alzheimer disease mouse models. Methods Mol Biol 2016;1303:117–23. · DOI
- Gal J, Bang Y, Choi HJ. SIRT2 interferes with autophagy-mediated degradation of protein aggregates in neuronal cells under proteasome inhibition. Neurochem Int 2012;61:992–1000. · DOI
- Gan L, Mucke L. Paths of convergence: sirtuins in aging and neurodegeneration. Neuron 2008;58:10–14. · DOI · Paper page
- Wongchitrat P, et al. Alterations in the expression of amyloid precursor protein cleaving enzymes mRNA in Alzheimer peripheral blood. Curr Alzheimer Res 2018;16:29–38. · DOI
- Wloga D, Joachimiak E, Fabczak H. Tubulin post-translational modifications and microtubule dynamics. Int J Mol Sci 2017;18:2207. · DOI · Paper page
- Yoo DY, et al. Sodium butyrate, a histone deacetylase Inhibitor, ameliorates SIRT2-induced memory impairment, reduction of cell proliferation, and neuroblast differentiation in the dentate gyrus. Neurol Res 2015;37:69–76. · DOI
- Theendakara V, et al. Neuroprotective Sirtuin ratio reversed by ApoE4. Proc Natl Acad Sci USA 2013;110:18303–8. · DOI · Paper page
- Porquet D, et al. Dietary resveratrol prevents Alzheimer’s markers and increases life span in SAMP8. Age (Dordr) 2013;35:1851–65. · DOI · Paper page
- Zhao Y, et al. Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat Cell Biol 2010;12:665–75. · DOI · Paper page
- Inoue T, et al. SIRT2 knockdown increases basal autophagy and prevents postslippage death by abnormally prolonging the mitotic arrest that is induced by microtubule inhibitors. FEBS J 2014;281:2623–37. · DOI
- Fonseca R. The aging memory: modulating epigenetic modifications to improve cognitive function. Neurobiol Learn Mem 2016;133:182–4. · DOI
- Magnusson KR, Nelson SE, Young AB. Age-related changes in the protein expression of subunits of the NMDA receptor. Brain Res Mol Brain Res 2002;99:40–45. · DOI
- Brim BL, et al. Memory in aged mice is rescued by enhanced expression of the GluN2B subunit of the NMDA receptor. Behav Brain Res 2013;238:211–26. · DOI
- Muñoz-Cobo I, et al. Nucleocytoplasmic export of HDAC5 and SIRT2 downregulation: two epigenetic mechanisms by which antidepressants enhance synaptic plasticity markers. Psychopharmacology (Berl) 2018;235:2831–46. · DOI
- Luo Y, et al. Reversal of aging-related emotional memory deficits by norepinephrine via regulating the stability of surface AMPA receptors. Aging Cell 2015;14:170–9. · DOI
- Wang B, et al. SIRT2 plays significant roles in lipopolysaccharides-induced neuroinflammation and brain injury in mice. Neurochem Res 2016;41:2490–2500. · DOI
- Moreno LCGEI, et al. Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer’s disease. Int J Pharm 2017;517:50–57. · DOI · Paper page
- Rancán L, et al. Protective effect of xanthohumol against age-related brain damage. J Nutr Biochem 2017;49:133–40. · DOI
- Cheng J, et al. Vitamin D combined with resveratrol prevents cognitive decline in SAMP8 mice. Curr Alzheimer Res 2017;14:820–33. · DOI
- Chen Z-J, Yang Y-F, Zhang Y-T, Yang D-H. Dietary total prenylflavonoids from the fruits of Psoralea corylifolia L. prevents age-related cognitive deficits and down-regulates Alzheimer’s markers in SAMP8 mice. Molecules 2018;23:196. · DOI
- Scuderi C, et al. Sirtuin modulators control reactive gliosis in an in vitro model of Alzheimer’s disease. Front Pharmacol 2014;5:89. · DOI
- Lee AS, et al. SIRT2 ameliorates lipopolysaccharide-induced inflammation in macrophages. Biochem Biophys Res Commun 2014;450:1363–9. · DOI
- Chen H, Wu D, Ding X, Ying W. SIRT2 is required for lipopolysaccharide-induced activation of BV2 microglia. Neuroreport 2015;26:88–93. · DOI
- Zhao T, et al. Selective inhibition of SIRT2 improves outcomes in a lethal septic model. Curr Mol Med 2015;15:634–41. · DOI
- Pais TF, et al. The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation. EMBO J 2013;32:2603–16. · DOI · Paper page
- Yuan F, et al. SIRT2 inhibition exacerbates neuroinflammation and blood-brain barrier disruption in experimental traumatic brain injury by enhancing NF-κB p65 acetylation and activation. J Neurochem 2016;136:581–93. · DOI
- Li Y, et al. SIRT2 down-regulation in HeLa can induce p53 accumulation via p38 MAPK activation-dependent p300 decrease, eventually leading to apoptosis. Genes Cells 2011;16:34–45. · DOI · Paper page
- He X, et al. SIRT2 activity is required for the survival of C6 glioma cells. Biochem Biophys Res Commun 2012;417:468–72. · DOI
- Lynn EG, McLeod CJ, Gordon JP, Bao J, Sack MN. SIRT2 is a negative regulator of anoxia-reoxygenation tolerance via regulation of 14-3-3 zeta and BAD in H9c2 cells. FEBS Lett 2008;582:2857–62. · DOI
Cited by
The sirtuin family in health and disease
Wu, Q.-J., Zhang, T.-N., Chen, H.-H., Yu, X.-F., Lv, J.-L., Liu, Y.-Y., Liu, Y.-S., Zheng, G., Zhao, J.-Q., Wei, Y.-F., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01257-8 · Cited by 862
Liu, B., Liu, J., & Shi, J.-S. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200063 · Cited by 156
Sumsuzzman, D. M., Khan, Z. A., Choi, J., & Hong, Y. (2021) · Aging · doi:10.18632/aging.202894 · Cited by 19
Sola-Sevilla, N., Garmendia-Berges, M., Aleixo, M., Mera-Delgado, M., Solas, M., Tordera, R. M., García-Carracedo, L., Expósito, S., Anaya-Cubero, E., Fernández-Irigoyen, J., et al. (2025) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2025.06.016 · Cited by 5
Self-citation
Metadata
- Authors
- Diaz-Perdigon, T., Belloch, F. B., Ricobaraza, A., Elboray, E. E., Suzuki, T., Tordera, R. M., & Puerta, E.
- Venue
- Neuropsychopharmacology
- Published
- 2019-08-30
- Volume
- 45
- Issue
- 2
- Pages
- 347-357
- ISSN
- 0893-133X
- 1740-634X
- Cited by
- 58
- References
- 3
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Funders
- Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (SAF2011-27910, SAF2017-87595-R)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Early sirtuin 2 inhibition prevents age-related cognitive decline in a senescence-accelerated mouse model. https://app.cochat.ai/papers/10.1038/s41386-019-0503-8
- The paper
- Diaz-Perdigon, T., Belloch, F. B., Ricobaraza, A., Elboray, E. E., Suzuki, T., Tordera, R. M., & Puerta, E. (2020). Early sirtuin 2 inhibition prevents age-related cognitive decline in a senescence-accelerated mouse model. Neuropsychopharmacology. https://doi.org/10.1038/s41386-019-0503-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.